Add to Basket Bulk discount
Order hotline:
+1 404 474 4654
+1 888 205 9894 (TF)

Transcriptional Adaptor 3 (TADA3) (C-Term) Peptide

Name

Transcriptional Adaptor 3 (TADA3)

Synonyms ADA3, NGG1, hADA3, TADA3L, FLJ20221, FLJ21329, Tada3, MGC114459
Binding Site

C-Term

2 references available
Certificates ISO 9001:2008
Catalog no. ABIN692723
Quantity 0.1 mg
Price 49.50 $   Plus shipping costs $45.00
Bulk discount
Shipping to
Availability Will be delivered in 2 to 3 Business Days

Additional Information

Immunogen Synthetic peptide
Characteristics Blocking peptide for TADA3L (C-term) antibody ABIN658691
Comments

Background: Many DNA-binding transcriptional activator proteins enhance the initiation rate of RNA polymerase II-mediated gene transcription by interacting functionally with the general transcription machinery bound at the basal promoter. Adaptor proteins are usually required for this activation, possibly to acetylate and destabilize nucleosomes, thereby relieving chromatin constraints at the promoter. The protein encoded by this gene is a transcriptional activator adaptor and has been found to be part of the PCAF histone acetylase complex. In addition, it associates with the tumor suppressor protein p53 and is required for full activity of p53 and p53-mediated apoptosis. At least four alternatively spliced variants have been found for this gene, but the full-length nature of some variants has not been determined. [provided by RefSeq].

Application Details

Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Restrictions For Research Use only

Publications

Product Wang, Faiola, Xu et al.: "Human ATAC Is a GCN5/PCAF-containing acetylase complex with a novel NC2-like histone fold module that interacts with the TATA-binding protein." in: The Journal of biological chemistry, Vol. 283, Issue 49, pp. 33808-15, 2008 (PubMed).

Hu, Ye, Lu et al.: "HPV16 E6-induced and E6AP-dependent inhibition of the transcriptional coactivator hADA3 in human cervical carcinoma cells." in: Cancer investigation, Vol. 27, Issue 3, pp. 298-306, 2009 (PubMed).